These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 903059)

  • 21. Drug interactions with urate excretion in man.
    Sommers DK; Schoeman HS
    Eur J Clin Pharmacol; 1987; 32(5):499-502. PubMed ID: 3622598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Uric acid-lowering effect of a combination of benzbromarone and allopurinol--studies under standardized dietary conditions].
    Löffler W; Gröbner W; Zöllner N
    Arzneimittelforschung; 1983; 33(12):1687-91. PubMed ID: 6686776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The uricosuric effect of benzbromaron and probenecid under fasting conditions (author's transl)].
    Schulz E; Schräpler P; Kleinschmidt A
    Med Klin; 1978 Feb; 73(7):240-6. PubMed ID: 628361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H
    Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term therapy with benzbromarone in uric arthritis].
    Bröll H; Sochor H; Tausch G; Eberl R
    Wien Med Wochenschr; 1975 Sep; 125(28):546-8. PubMed ID: 816095
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
    Matzkies F
    Fortschr Med; 1978 Aug; 96(32):1619-21. PubMed ID: 680625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
    Moriwaki Y; Yamamoto T; Takahashi S; Hada T; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):84-8. PubMed ID: 2307550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzbromarone therapy in management of refractory gout.
    Kumar S; Ng J; Gow P
    N Z Med J; 2005 Jun; 118(1217):U1528. PubMed ID: 15980902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of benzbromarone and allopurinol on adiponectin in vivo and in vitro.
    Inokuchi T; Tsutsumi Z; Takahashi S; Ka T; Yamamoto A; Moriwaki Y; Masuzaki H; Yamamoto T
    Horm Metab Res; 2009 Apr; 41(4):327-32. PubMed ID: 19048458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Benzbromarone in the treatment of gout].
    Kawenoki-Minc E; Brzozowska-Jurkowska AM
    Reumatologia; 1980; 18(1):61-7. PubMed ID: 6994191
    [No Abstract]   [Full Text] [Related]  

  • 32. Ten years' experience with benzbromarone in the management of gout and hyperuricaemia.
    Masbernard A; Giudicelli CP
    S Afr Med J; 1981 May; 59(20):701-6. PubMed ID: 7221794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Action of benzbromarone on the renal excretion of allantoin in normouricemic and hyperuricemic humans (author's transl)].
    Janzen D; Mertz DP; Scheiffele E; Kühnhold O
    Klin Wochenschr; 1977 Nov; 55(21):1071-3. PubMed ID: 926719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal handling of uric acid in man.
    Levinson DJ; Decker DE; Sorensen LB
    Ann Clin Lab Sci; 1982; 12(1):73-7. PubMed ID: 7065639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cimetidine on serum uric acid concentration.
    Berardi RR; Hyneck ML; Cohen IA; Cornish LA; Achem SR
    Clin Pharm; 1984; 3(1):56-9. PubMed ID: 6697675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone.
    Yu TF
    J Rheumatol; 1976 Sep; 3(3):305-12. PubMed ID: 978666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzbromarone therapy in hyperuricaemia.
    Scott WA
    J Int Med Res; 1981; 9(1):82-7. PubMed ID: 7009259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Benzbromarone in the treatment of hyperuricemias].
    Ravera R
    Minerva Med; 1975 Mar; 66(17):783-800. PubMed ID: 1093064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.